Chinanews.com, Shanghai News, April 25 (Reporter Jiang Yu) The professional dermatology company Galderma held a press conference in Shanghai on the 24th, announcing that its hyaluronic acid product ® Restylane Volyme (cross-linked sodium hyaluronate gel for injection) using OBT gel technology was officially launched in China. The product is used to correct the loss of volume and/or the contour of the middle face, and the injection level is subcutaneous, supraperiosteum.
(Restylane Harvest & "Personality Enhancement Beauty" Facial Aesthetic Treatment Program Officially Launched)
Restylane Riche ® uses Galderma's innovative OBT (Optimal Balance Technology) hyaluronic acid gel technology to provide superior stretch and support to create a natural and dynamic volume boost. U.S. registered clinical studies have shown that Restylane Harvest ® can achieve the same aesthetic results as the control group with a lower injection volume, with 98% of subjects satisfied with the results after 18 months of injection.
On the same day, Galderma also launched the "Personality Enhancement Beauty" facial aesthetic treatment program jointly developed with global medical aesthetic injection experts. This solution solves the problems of mid-face collapse and sagging according to individual beauty needs, and realizes the aesthetic needs of lifting and shaping.
(Lei Hongyu, General Manager of Galderma China)
Ms. Lei Hongyu, General Manager of Galderma China, said: "Galderma has always been committed to the development and production of scientific, safe and high-value high-quality products and personalized treatment solutions. The launch of Restylane Harvest ® marks the establishment of the hyaluronic acid 'dynamic filling' segment. The rich product portfolio and personalized beauty diagnosis and treatment series solutions have led the industry into a new era of anti-aging 3.0 'personalized aesthetic holistic treatment plan'. ”
Per Winlof, chief design expert of Galderma Gel R&D Department, said in an interview with Chinanews during the press conference that beauty seekers attach the most importance to safety, and the safety of medical cosmetology directly affects the health and life safety of patients. Due to the particularity of plastic surgery operations, some unqualified doctors or medical institutions may have problems such as improper operation, substandard equipment or unqualified products, which bring potential risks to the health of beauty seekers, so safety issues are increasingly emphasized.
"The Restylane portfolio features two gel technologies, NASHA® and OBT, which deliver personalized, natural-looking results that lead to long-term satisfaction and personal confidence. Restylane has a guaranteed safety profile, with over 27 years of experience, more than 160 clinical articles, and 55 million treatments performed worldwide, and the number is growing. Per Winlof said.
According to the research data of Meibei Medical Aesthetics, the demand for mid-face treatment ranks first among high-end hyaluronic acid seekers, with 60% of respondents receiving mid-face injections (nasal base/nasolabial folds, apple muscle, cheeks, etc.) in the past year. With age and natural bone aging, the midface is prone to slight sagging, and 65% of patients are concerned that filler injections in the midface may cause stiffness or unnaturalness of the face. Focusing on the mid-face and creating a plump and flexible appearance has become the core demand of many beauty seekers.
Restylane is ® Galderma's second Lidocaine-based OBT gel technology hyaluronic acid product launched in the Chinese market, which has excellent stretching force and creates a natural and dynamic volume lifting effect. Clinical studies have shown that a single injection can achieve facial plumping results for up to 18 months, and 98% of subjects are satisfied with the results, and 100% of subjects are willing to recommend it to a friend and receive treatment again.
(Industry experts discuss the high-quality development of the medical aesthetic market)
Cui Haiyan, Director of the Institute of Plastic Surgery and Anti-Aging at Tongji University School of Medicine, Director of the Department of Plastic and Cosmetic Surgery at Tongji Hospital, Tongji University, Chief Physician and Doctoral Supervisor, said: "Facial expressions are controlled by 42 facial muscles to express various emotions such as joy, anger, sadness, and happiness, and participate in activities such as speech and chewing. Mid-face appearance is critical in interpersonal communication. With the superior stretch power brought by OBT gel technology, Restylane Harvest ® can correct the volume loss and contour defects of the midface, improve or maintain the youthful and natural dynamic expression of the face, and achieve a natural, plumped and long-lasting mid-face dynamic filling aesthetic effect. ”
"Natural dynamic expression" is an important feature of "personality beauty", and it is the key to achieving interpersonal communication and genuine interaction. OBT gel technology can achieve a perfect fit with dynamic expressions, improving the lack of volume, three-dimensional shaping, and allowing beauty seekers to indulge in expressing their emotions.
As the world's first and only hyaluronic acid technology that has been evaluated for the dynamic naturalness of five expressions after injection, OBT gel technology products can effectively improve or maintain the youthful and natural dynamic expression of the face. The data shows that there are no reports of unexpected adverse reactions in 1 million cases of OBT products worldwide. Restylane Harvest ® and Restylane Dingcai ® are two OBT gel technology products, which respectively address the needs of facial aesthetic treatment such as volume loss and contour defects in the middle face, as well as jaw contour improvement and nasolabial fold wrinkle correction, empowering aesthetic doctors to achieve a younger, smart and natural appearance for beauty seekers.
Professor Li Qin, President of the Facial Rejuvenation Branch of the China Plastic Surgery Association and Professor of AST Medical Aesthetic Group, said: "The OBT gel technology balances the G' value (elastic modulus) and the xStrain value (stretching parameter) to provide excellent stretching force and good support for the face. When the patients who received OBT gel injection did their facial expressions, the stretching of the facial tissues was closer to the state of young people, which met the aesthetic needs of the majority of beauty seekers for dynamic shaping. ”
Jointly developed by Galderma and global medical aesthetic injection experts, the "Personalized Aesthetic Holistic Treatment Solution" (HIT) is based on comprehensive physical evaluation and anatomical analysis, combined with Galderma's rich aesthetic product portfolio, to provide patients with a unique facial aesthetic customized treatment plan. After launching the "Balanced Profile" treatment program in China last year, Galderma launched the second facial aesthetic treatment program of HIT in China this year - "Shape Up".
Focusing on the mid-face areas that are of common concern to Asian beauty seekers, focusing on the plumping and lifting of the mid-face, the "Personality Enhancement Beauty" treatment program brings better results and satisfaction to the mid-face through a scientific portfolio of hyaluronic acid fillers. Restylane Rich ®, with the Restylane Trim ®, Restylane Radisson LidoTM ® series product portfolio and the "Beauty of Personality Enhancement" treatment program, can be tailored to the different needs of different groups of people, using accurate and efficient scientific dosage to personalize the needs of mid-face lifting, volumizing, etc., and solve problems such as collapse, sagging, and volume loss. Among them, Restylane Lido ® LottoTM adopts Galderma's original NASHA® gel technology, which has a high G' value (elastic modulus) and excellent retention characteristics, which is suitable for structural lifting of bony parts of the face, and has been approved for 3 major indications in China. In addition, Restylane Dingcai ® is the first hyaluronic acid filler approved for the indication of the lower jaw in China, which uses OBT gel technology to take into account both support and stretching power, which is suitable for the dynamic shaping needs of the jaw area.
Restylane ® is the first "animal-origin-free" sodium hyaluronate filler brand approved in Europe, the U.S. and China, and has been on the market for more than 26 years, and has become a leader in the industry thanks to its extensive clinical trial data and long-term safety record.
Galderma is committed to becoming a global leader in the field of dermatology, and continues to promote "every progress, for every inch of skin". The launch of Autonavi Merry Blue and ® the launch of the "Personality Enhancement Beauty" facial aesthetic treatment program will help professional medical aesthetic doctors to jointly realize the pursuit of personalized aesthetics for dynamic facial sculpting. (ENDS)
Editor: Jiang Yu